StrideBio, Inc.
Gene therapies for life-threatening diseases
- Sector
- Biotech
- Headquarters
- DURHAM, NC
- Founded
- 2015
- Latest Form D
- $48.9M, Mar 2021
- Total capital
- $57.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $57.7M
- 3 Form D · last Mar 2021
- 67 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 27 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$48.9M
- Private capital raisedForm D · SEC · 2nd filing$7.7M
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Aravind AsokanDirectorNamed in SEC Form D filings
- Clay ThorpDirectorNamed in SEC Form D filings
- Erica WhittakerDirectorNamed in SEC Form D filings
- Karen HongDirectorNamed in SEC Form D filings
- Maritza McIntyreExecutive OfficerNamed in SEC Form D filings
- Mavis Abjandje-McKennaDirectorNamed in SEC Form D filings
Show all 16 people
- Mavis Agbandje-McKennaDirector, PromoterNamed in SEC Form D filings
- Michael MartinDirectorNamed in SEC Form D filings
- Mike DialDirectorNamed in SEC Form D filings
- Patrick RitschelExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Richard SmithExecutive OfficerNamed in SEC Form D filings
- Robert HughesExecutive OfficerNamed in SEC Form D filings
- Sapan ShahExecutive Officer, DirectorNamed in SEC Form D filings
- Shaan GandhiDirectorNamed in SEC Form D filings
- Stewart ParkerDirectorNamed in SEC Form D filings
- William MonteithExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 27- PendingAav Transfer CassetteUSPTOApplication 17769615
- PendingGene Therapy For Arrhythmogenic CardiomyopathyUSPTOApplication 63383639
- PendingRecombinant Adeno-associated Virus Vectors, And Methods Of Use ThereofUSPTOApplication 63339366
Show all 27 patent records
- Aav Transfer CassetteApr 25, 2024 · Application 17769615Pending
- Gene Therapy For Arrhythmogenic CardiomyopathyApplication 63383639Pending
- Recombinant Adeno-associated Virus Vectors, And Methods Of Use ThereofApplication 63339366Pending
- Gene Therapy For Arrhythmogenic CardiomyopathyApplication 63311840Pending
- Recombinant Adeno-associated Virus Vectors, And Methods Of Use ThereofApplication 63306890Pending
- Aav Vectors Targeting T-cellsApplication 63137497Pending
- Adeno-associated Viral Vectors For Treatment Of Niemann-pick Disease Type CApplication PCTUS2020056031Pending
- Aav Transfer CassetteApplication PCTUS2020056015Pending
- Adeno-associated Viral Vectors For Treatment Of Niemann-pick Disease Type-cApplication 63082899Pending
- Adeno-associated viral vectors for treatment of Niemann-Pick Disease Type CApplication 63082425Pending
- Adeno-associated Virus Vectors For Treatment Of Rett SyndromeApplication 63067668Pending
- Recombinant Adeno-associated Virus VectorsApplication PCTUS2020023877Pending
- Recombinant Viral Vectors And Nucleic Acids For Producing The SameApplication PCTUS2019062531Pending
- Aav Transfer CassetteApplication 62923253Pending
- Aav Transfer CassetteApplication 62916749Pending
- Antibody-evading Virus VectorsApplication PCTUS2019025617Pending
- Virus Vectors For Targeting Ophthalmic TissuesApplication PCTUS2019025584Pending
- Antibody-evading Virus VectorsApplication PCTUS2019025610Pending
- Recombinant Adeno-associated Virus VectorsApplication 62821710Pending
- Antibody-evading Virus VectorsApplication 62776793Pending
- Antibody-evading Virus VectorsApplication 62776814Pending
- Antibody-evading Virus VectorsApplication 62770240Pending
- Recombinant Adeno-associated Virus And Methods For Producing The SameApplication 62770202Pending
- Antibody-evading Virus VectorsApplication 62652111Pending
- Antibody-evading Virus VectorsApplication 62652103Pending
- Gene Therapy For Arrhythmogenic CardiomyopathyApplication PCTUS2023062834Pending
- Virus Vectors For Targeting Ophthalmic TissuesApplication 62652108Pending
Related companies, and why
- SENTRIMED, INC.Similar federal contract value in Biotech · null in contracts
- Oleander Medical Technologies LLCSimilar federal contract value in Biotech · null in contracts
- ACUMEN PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- Alveus Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- ARIDIS PHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
- FirstString Research, IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .